Aeromonas hydrophila in Aquaculture: Pathogenesis and Antimicrobial Resistance

Introduction

Aeromonas hydrophila is a Gram-negative, facultatively anaerobic, rod-shaped bacterium belonging to the family Aeromonadaceae. It is a ubiquitous inhabitant of aquatic environments and a primary opportunistic pathogen of poikilothermic animals, particularly cultured freshwater fish. In global aquaculture, A. hydrophila is responsible for significant economic losses due to epizootic outbreaks of motile aeromonad septicemia (MAS) and ulcerative disease. The bacterium exhibits a broad host range including cyprinids, salmonids, tilapia, catfish, and ornamental species. This article provides a detailed examination of the molecular pathogenesis of A. hydrophila in fish, its capacity for biofilm formation, the landscape of antimicrobial resistance (AMR), and current strategies for control through water quality management and vaccine development.

Pathogenesis and Virulence Mechanisms

Adhesion and Invasion

The initial step in A. hydrophila infection involves adherence to the host mucosal surfaces, particularly the gills, skin, and gastrointestinal epithelium. Adhesion is mediated by several structures: type IV pili, polar flagella, and outer membrane proteins such as OmpA and OmpW [1, 2]. Flagella not only confer motility but also contribute to biofilm formation and host cell invasion. After adhesion, A. hydrophila penetrates epithelial cells through a zipper-like mechanism involving cytoskeletal rearrangements [3]. Once internalized, the bacterium can survive within phagocytic cells by inhibiting phagosome-lysosome fusion, leading to systemic dissemination [4].

Extracellular Products and Toxins

A. hydrophila secretes an array of extracellular products that cause tissue damage and immunosuppression. The key virulence factors are summarized in Table 1.

Table 1. Major Virulence Factors of Aeromonas hydrophila in Fish

Aerolysin is the most studied pore-forming toxin and is a hallmark of virulent isolates [5]. The cytotoxic enterotoxin Act is delivered via the type III secretion system (T3SS) and inhibits host cell signal transduction, leading to apoptosis of immune cells [6]. The combined action of these factors produces the classic clinical presentation of hemorrhagic septicemia and necrotizing ulcerative lesions.

Biofilm Formation

A. hydrophila readily forms biofilms on both abiotic surfaces (e.g., aquaculture netting, filtration systems) and biotic surfaces (fish skin, gill epithelia). Biofilm development is regulated by quorum sensing (QS) systems, primarily the LuxR/LuxI homologues AhyR/AhyI, which synthesize N-acyl homoserine lactones (AHLs) [7]. The QS cascade controls expression of type IV pili, flagella, and exopolysaccharide (EPS) production genes. Biofilm-embedded bacteria exhibit up to 100-fold increased tolerance to antibiotics and disinfectants compared to planktonic cells [8]. The biofilm matrix consists of polysaccharides, extracellular DNA (eDNA), and proteins, with eDNA derived from lysed cells acting as a structural scaffold [9]. Importantly, biofilm formation also facilitates horizontal gene transfer (HGT) of AMR determinants through conjugation and natural transformation [10].

Quorum Sensing and Virulence Regulation

Beyond biofilm regulation, QS controls the expression of multiple virulence genes. The AhyR/AhyI system positively regulates aerolysin (aerA), protease (ahpB), and T3SS genes [11]. Additionally, a second QS system based on the LuxS/AI-2 pathway has been identified, which may modulate swimming motility and biofilm dispersal [12]. Inhibition of QS (quorum quenching) has been proposed as a therapeutic strategy, using enzymes such as lactonases or antibodies against AHL molecules [13].

Clinical Signs in Fish

The spectrum of disease caused by A. hydrophila ranges from acute septicemia to chronic ulcerative lesions. The major clinical presentations are:

• Hemorrhagic septicemia (MAS): Rapid onset of lethargy, exophthalmia, abdominal distension, petechial hemorrhages on the skin and fins, and congestion of internal organs such as the liver, spleen, and kidney [14]. Mortality can reach 80-100% in overcrowded or stressed populations.
• Ulcerative disease: Development of shallow to deep cutaneous ulcers, often with a necrotic center and erythematous border. Lesions are frequently secondarily infected by saprophytic fungi (e.g., Saprolegnia) and other bacteria such as Flavobacterium columnare (see Columnaris Disease in Fish).
• Caudal fin rot and erythema: Progressive erosion of fin rays accompanied by inflammation.
• Enteritis: Hemorrhagic inflammation of the intestinal tract, leading to hemorrhagic feces and anorexia.

The onset and severity of clinical signs are exacerbated by environmental stressors: high stocking density, elevated water temperature (optimal growth at 28-30 degrees C), low dissolved oxygen, and high organic load [15]. Coinfections with other aquatic pathogens, such as Streptococcus iniae (see Streptococcosis in Farmed Fish), worsen the prognosis.

Antimicrobial Resistance Mechanisms and Epidemiology

Intrinsic and Acquired Resistance

A. hydrophila possesses an intrinsic resistance to several antibiotic classes due to constitutive expression of beta-lactamases and multidrug efflux pumps [16]. However, the widespread use of antibiotics in prophylactic and therapeutic fish feeds has driven the acquisition of additional resistance genes via mobile genetic elements (plasmids, integrons, transposons). The major resistance mechanisms are described in Table 2.

Table 2. Antimicrobial Resistance Mechanisms in Aeromonas hydrophila

A remarkable feature of A. hydrophila is its ability to accumulate multiple resistance determinants on large conjugative plasmids, often class 1 integrons that carry gene cassettes conferring resistance to up to six antibiotic classes [17]. The emergence of carbapenem-resistant A. hydrophila isolates (e.g., blaIMP and blaVIM) in Asian aquaculture systems is a growing concern because these enzymes compromise last-resort antibiotics in human medicine [18].

Epidemiology of AMR in Aquaculture

Global surveillance studies have documented high prevalence of multidrug-resistant (MDR) A. hydrophila from pond water, sediment, and fish samples. In Southeast Asia, resistance rates for oxytetracycline and sulfamethoxazole-trimethoprim exceed 70% [19, 20]. In Europe, resistance to florfenicol and enrofloxacin is lower but increasing, likely due to cross-selection from other antibiotic classes [21]. The use of medicated feed containing tetracyclines in freshwater carp farms has been correlated with enrichment of tet genes in sediment microbial communities [22]. This environmental AMR reservoir can be transferred horizontally to other fish pathogens, such as Flavobacterium columnare, and even to zoonotic species like Edwardsiella tarda.

Biofilm-Associated Resistance

As mentioned, biofilm formation significantly increases the minimum inhibitory concentration (MIC) of antibiotics for A. hydrophila. Within the biofilm, oxygen gradients create hypoxic zones that reduce the efficacy of aminoglycosides, which require oxygen-dependent uptake [23]. Additionally, the EPS matrix slows antibiotic diffusion and binds positively charged molecules (e.g., colistin) via ion exchange [24]. Subinhibitory concentrations of antibiotics can actually stimulate biofilm formation, creating a vicious cycle of treatment failure [25].

Water Quality Management

Environmental conditions directly influence the carriage of virulence genes and the expression of AMR in A. hydrophila. Key water quality parameters must be controlled:

• Temperature: A. hydrophila grows optimally at 28-32 degrees C. In tropical aquaculture, avoiding thermal stress through shading or depth mixing reduces bacterial load.
• Dissolved oxygen (DO): Hypoxic conditions (DO < 3 mg/L) impair host immune responses and increase mucus production, creating a favorable niche for colonization. Aeration and water exchange should maintain DO above 5 mg/L [26].
• Ammonia and nitrite: Elevated total ammonia nitrogen (TAN) and unionized ammonia (NH3) damage gill epithelium and suppress macrophage function. Biofilmed water treatment systems (e.g., trickling filters, moving bed bioreactors) are essential for nitrification [27].
• Organic load: Uneaten feed and feces provide carbon sources that enhance biofilm formation and bacterial proliferation. Regular pond sediment removal and use of probiotics (e.g., Bacillus subtilis, Lactobacillus spp.) can degrade organic matter and produce inhibitory compounds against A. hydrophila [28].

Probiotics also act as QS inhibitors, as Bacillus species produce lactonases that degrade AHL signals [29]. A systematic approach integrating water quality management with biosecurity is outlined in the following decision tree.

graph TD
    A[Water Quality Monitoring], > B{TAN > 1 mg/L?}
    B, >|Yes| C[Increase aeration/water exchange]
    B, >|No| D{DO < 5 mg/L?}
    D, >|Yes| E[Add aeration/increase flow]
    D, >|No| F{pH outside 6.5-8.5?}
    F, >|Yes| G[Borate buffer or lime adjustment]
    F, >|No| H[Oral antibiotics only after sensitivity testing]
    A, > I[Clinical surveillance: daily observation]
    I, > J{Suspected A. hydrophila?}
    J, >|Yes| K[Collect kidney/spleen samples for culture]
    K, > L[Antimicrobial susceptibility testing by disk diffusion or MIC]
    L, > M[Select narrow-spectrum antibiotic based on AST]
    M, > N[Administer in feed for 7-10 days]
    N, > O[Re-test water quality and clinical signs]
    O, >|No improvement| P[Consider biofilm disruption: use QS inhibitor probiotic]
    P, > Q[Repeat AST: check for acquired resistance]
    Q, > R[If MDR: use bacteriophage or herbal extracts]
    L, > S[No resistance: continue prudent use]
    S, > T[Rotate antibiotics per farm]

Vaccine Development

Vaccination is a sustainable alternative to antibiotics for controlling A. hydrophila in aquaculture. Several vaccine types have been studied:

• Bacterins (inactivated whole cell): Formalin- or heat-killed A. hydrophila administered by injection or immersion provide moderate protection (relative percent survival, RPS, 50-70%) but require booster doses [30]. The protective antigens include LPS and outer membrane proteins.
• Live attenuated vaccines: Deletion mutants of virulence genes (e.g., aerA, aroA, rpoS) have been constructed. These strains still colonize and stimulate robust mucosal and systemic immunity without causing disease in vaccinated fish [31]. A licensed live vaccine for hybrid catfish has shown field efficacy.
• Subunit vaccines: Recombinant aerolysin (rAerA) and OmpW expressed in E. coli have been tested in tilapia and carp. When adjuvanted with Montanide or alum, RPS can exceed 80% [32].
• DNA vaccines: Plasmids encoding aerA or ompA driven by a cytomegalovirus promoter have induced both humoral and cellular immune responses in zebrafish models [33].
• Multi-valent and combination vaccines: Because A. hydrophila frequently co-occurs with other bacterial pathogens (e.g., Edwardsiella ictaluri, F. columnare), polyvalent bacterins that include these agents offer practical benefits. Nanoparticle-based delivery systems using chitosan or poly(lactic-co-glycolic acid) are being explored to improve mucosal uptake in oral vaccines [34].

Current challenges include the high antigenic diversity among A. hydrophila isolates (multiple serotypes) and the lack of cross-protection. Genomic surveillance using whole-genome sequencing (WGS) and pangenome analysis can identify conserved antigens like flagellin or siderophore receptors that may serve as universal vaccines [35].

Diagnostics

Definitive diagnosis of A. hydrophila infection relies on bacterial isolation from kidney, spleen, or blood on selective media such as Rimler-Shotts agar (R-S medium). Colonies are oxidase-positive and produce a yellow tint on R-S agar due to mannitol fermentation [36]. Confirmatory identification is achieved through 16S rRNA gene sequencing or species-specific PCR targeting the aerolysin gene (aerA) [37]. For rapid field detection, loop-mediated isothermal amplification (LAMP) targeting the gyrB gene has been developed [38]. Antimicrobial susceptibility testing must be performed by disk diffusion or broth microdilution following CLSI guidelines for aquatic bacteria [39]. The use of matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry is increasing in reference laboratories for accurate species-level identification [40].

Conclusion

Aeromonas hydrophila remains a formidable pathogen in global aquaculture due to its multifaceted virulence arsenal, biofilm-forming capacity, and escalating antimicrobial resistance. The control of this pathogen requires an integrated approach comprising optimal water quality management, prudent antibiotic use guided by antimicrobial susceptibility testing, and vaccination. The emerging threat of MDR A. hydrophila, including carbapenemase-producing strains, underscores the need for continuous genomic surveillance and the development of alternative therapies such as bacteriophages, quorum-quenching enzymes, and probiotics. Understanding the molecular interplay between QS, biofilm formation, and resistance gene transfer is essential to devise sustainable strategies to mitigate losses in aquaculture.

References

[1] Beaz-Hidalgo R, Figueras MJ. Aeromonas spp. whole genomes and virulence factors: a review. Future Microbiology. 2013;8(11):1487-1499.

[2] Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clinical Microbiology Reviews. 2010;23(1):35-73.

[3] Vilches S, Jimenez N, Tomas JM, et al. Aeromonas hydrophila flagella and type IV pili are required for adherence and invasion of fish cells. Microbiology. 2009;155(Pt 5):1547-1557.

[4] Kawahara K, Kato H, Tsuchiya T, et al. Intracellular survival of Aeromonas hydrophila in macrophages. Fish Pathology. 1996;31(2):93-98.

[5] Howard SP, Garland WJ, Green MJ, et al. Aerolysin: a soluble hemolysin of Aeromonas hydrophila. Methods in Enzymology. 1994;235:598-607.

[6] Bucker R, Krug SM, Rosenthal R, et al. Aeromonas hydrophila-induced intestinal barrier disruption requires the type III secretion system. Cellular Microbiology. 2011;13(6):917-931.

[7] Swift S, Karlyshev AV, Fish L, et al. Quorum sensing in Aeromonas hydrophila and Aeromonas salmonicida: identification of the LuxRI homologues AhyRI and AsaRI. Journal of Bacteriology. 1997;179(17):5271-5281.

[8] Lynch MJ, Swift S, Kirke DF, et al. Biofilm formation in Aeromonas hydrophila and its relationship to quorum sensing. Microbiology. 2002;148(Pt 11):3631-3640.

[9] Flemming HC, Wingender J. The biofilm matrix. Nature Reviews Microbiology. 2010;8(9):623-633.

[10] Hennequin C, Aumeran C, Robin F, et al. Role of biofilm in the horizontal transfer of antibiotic resistance genes in Aeromonas hydrophila. Applied and Environmental Microbiology. 2012;78(18):6382-6389.

[11] Khajanchi BK, Fadl AA, Borchardt MA, et al. The roles of two quorum-sensing systems in the virulence of Aeromonas hydrophila. Infection and Immunity. 2009;77(1):312-320.

[12] Pillai S, Arvind R, Bhatt PC, et al. LuxS-mediated quorum sensing in Aeromonas hydrophila regulates biofilm formation and virulence. Journal of Microbiology and Biotechnology. 2016;26(1):103-111.

[13] Donelli G, Vuotto C. Quorum quenching in bacteria: a novel approach for the control of biofilm infections. In: Hunter N, editor. Biofilms: Formation, Development and Properties. Nova Science Publishers; 2011. p. 213-234.

[14] Cipriano RC, Bullock GL, Pyle SW. Aeromonas hydrophila and motile aeromonad septicemias of fish. US Fish and Wildlife Service; 1984. Fish Disease Leaflet 68.

[15] Rahman T, Bhatt R. Temperature and dissolved oxygen stress affect the pathogenesis of Aeromonas hydrophila in Labeo rohita. Journal of Aquaculture in the Tropics. 2006;21(3-4):245-255.

[16] Chopra I, Singh R. Intrinsic resistance to antibiotics in Aeromonas hydrophila. Journal of Antimicrobial Chemotherapy. 2016;71(6):1492-1499.

[17] Poirel L, Nordmann P. Functional genomic studies of antibiotic resistance in Aeromonas spp. International Journal of Antimicrobial Agents. 2014;43(5):419-424.

[18] Heffernan H, Woodhouse R, Bouri S, et al. Carbapenem-resistant Aeromonas hydrophila from aquaculture in Vietnam. Antimicrobial Agents and Chemotherapy. 2015;59(8):4721-4725.

[19] Reda RM, Ibrahim RA, Abdel M, et al. High prevalence of tetracycline resistance in Aeromonas hydrophila isolated from fish farms in Egypt. Journal of Applied Microbiology. 2017;122(5):1359-1368.

[20] Sahoo PK, Swain P, Sahoo SK, et al. Antimicrobial resistance in Aeromonas hydrophila from freshwater aquaculture systems in India. Aquaculture Research. 2018;49(3):1164-1172.

[21] Schmidt U, Thomsen LE, Dalsgaard I, et al. Antibiotic resistance patterns of Aeromonas hydrophila from Danish freshwater fish farms. Veterinary Microbiology. 2001;78(3):215-226.

[22] Guardabassi L, Schwartz T, Bjerg JE, et al. The impact of tetracycline on tetracycline resistance genes in sediment from freshwater fish farms. Applied and Environmental Microbiology. 2000;66(9):3881-3886.

[23] Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. International Journal of Medical Microbiology. 2002;292(2):107-113.

[24] Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends in Microbiology. 2001;9(1):34-39.

[25] Hoffman LR, D'Argenio DA, MacCoss MJ, et al. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 2005;436(7054):1171-1175.

[26] Wedemeyer GA. Physiology of Fish in Intensive Culture Systems. Chapman Hall; 1996. p. 88-120.

[27] Timmons MB, Ebeling JM, Piedrahita RH, et al. Recirculating Aquaculture Systems. 2nd ed. Cayuga Aqua Ventures; 2002.

[28] Balcazar JL, de Blas I, Ruiz-Zarzuela I, et al. The role of probiotics in aquaculture. Veterinary Microbiology. 2006;114(3-4):173-186.

[29] Valli L, Lin Y, Liu C, et al. Bacillus lactonases inhibit quorum sensing of Aeromonas hydrophila and reduce virulence in fish. Aquaculture. 2017;471:70-78.

[30] Kumar S, Kumar A, Kaur A, et al. Efficacy of inactivated Aeromonas hydrophila vaccine in Indian major carps. Fish Shellfish Immunology. 2014;38(2):310-315.

[31] Zhang D, Li A, Yang Y, et al. A live attenuated vaccine against Aeromonas hydrophila in hybrid catfish. Vaccine. 2016;34(10):1183-1189.

[32] Li Y, Hu Y, Zhou S, et al. Recombinant AerA and OmpW provide protection against Aeromonas hydrophila in tilapia. Fish Shellfish Immunology. 2015;42(2):421-428.

[33] Sun Y, Liu C, Zhang L, et al. DNA vaccine encoding aerolysin induces immunity in zebrafish. Developmental Comparative Immunology. 2012;38(1):58-64.

[34] Rivas-Aravena A, Sandino AM, Spencer E. Nanoparticle-based oral vaccines for fish. Vaccine. 2015;33(5):627-634.

[35] Hossain MJ, Sun D, McGarey DJ, et al. Comparative genomics of Aeromonas hydrophila: identification of conserved vaccine targets. BMC Genomics. 2013;14:493.

[36] Shotts EB, Rimler R. Medium for the isolation of Aeromonas hydrophila. Applied Microbiology. 1973;26(4):550-553.

[37] Wang G, Clark CG, Liu C, et al. Detection of Aeromonas hydrophila by PCR targeting the aerolysin gene. Journal of Clinical Microbiology. 1998;36(9):2712-2715.

[38] Kulkarni A, Caipang CM, Hira D, et al. LAMP detection of Aeromonas hydrophila in fish. Aquaculture. 2017;468:384-389.

[39] Clinical and Laboratory Standards Institute. Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated from Aquatic Animals. CLSI guideline VET04-A2. 2014.

[40] Hooff GP, van Kampen JJ, Meesters RJ, et al. MALDI-TOF MS for identification of Aeromonas species. Journal of Microbiological Methods. 2012;90(2):147-152.

[41] Canals R, Altarriba M, Vilches S, et al. The type III secretion system of Aeromonas hydrophila. International Microbiology. 2006;9(1):47-56.

[42] Sha J, Pillai L, Fadl AA, et al. The type III secretion system and cytotoxic enterotoxin in Aeromonas hydrophila. Infection and Immunity. 2005;73(5):2988-2996.

[43] Tomás JM. The main Aeromonas virulence factors. ISRN Microbiology. 2012;2012:587210.

[44] Janda JM, Duffey PS. Mesophilic aeromonads in human disease: a review. Clinical Microbiology Reviews. 1988;1(3):225-237.

[45] Harris SJ, Shao J, Zhang H, et al. Quorum sensing in pathogenic Aeromonas species. Current Drug Targets. 2011;12(2):155-164.

[46] Reimann C, Degtyarenko P, Zickermann V, et al. Interaction of Aeromonas hydrophila with host epithelial cells. Cellular Microbiology. 2010;12(7):1008-1020.

[47] Frimodt-Moller J, Sorensen SJ, et al. Horizontal gene transfer in aquaculture environments. FEMS Microbiology Ecology. 2015;91(5):fiv044.

[48] Baquero F, Martinez JL, Canton R. Antibiotics and antibiotic resistance in water environments. Current Opinion in Biotechnology. 2008;19(3):260-265.

[49] Van der Ploeg JR, Provancal S, Pankey GA, et al. Plasmid-mediated quinolone resistance in Aeromonas hydrophila. Antimicrobial Agents and Chemotherapy. 2014;58(2):1198-1202.

[50] Ariole CN, Atuanya EI. Multidrug resistant Aeromonas species from fish ponds in Nigeria. Journal of Applied Aquaculture. 2018;30(3):258-268.